BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eslami-S Z, Cortés-Hernández LE, Alix-Panabières C. Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells. Cells 2020;9:E1836. [PMID: 32764280 DOI: 10.3390/cells9081836] [Cited by in Crossref: 13] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Słomka A, Wang B, Mocan T, Horhat A, Willms AG, Schmidt-Wolf IGH, Strassburg CP, Gonzalez-Carmona MA, Lukacs-Kornek V, Kornek MT. Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts? Theranostics 2022;12:5836-55. [PMID: 35966579 DOI: 10.7150/thno.73400] [Reference Citation Analysis]
2 Kwizera EA, Ou W, Lee S, Stewart S, Shamul JG, Xu J, Tait N, Tkaczuk KHR, He X. Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS-Titanium-Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell Release. ACS Nano 2022. [PMID: 35797466 DOI: 10.1021/acsnano.2c05195] [Reference Citation Analysis]
3 Doswald S, Herzog AF, Zeltner M, Zabel A, Pregernig A, Schläpfer M, Siebenhüner A, Stark WJ, Beck-schimmer B. Removal of Circulating Tumor Cells from Blood Samples of Cancer Patients Using Highly Magnetic Nanoparticles: A Translational Research Project. Pharmaceutics 2022;14:1397. [DOI: 10.3390/pharmaceutics14071397] [Reference Citation Analysis]
4 Chien H, Wu J, Chang Y, Tsai W. Polycarboxybetaine-Based Hydrogels for the Capture and Release of Circulating Tumor Cells. Gels 2022;8:391. [DOI: 10.3390/gels8070391] [Reference Citation Analysis]
5 Li C, He W, Wang N, Xi Z, Deng R, Liu X, Kang R, Xie L, Liu X. Application of Microfluidics in Detection of Circulating Tumor Cells. Front Bioeng Biotechnol 2022;10:907232. [DOI: 10.3389/fbioe.2022.907232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rodríguez‐pena A, Armendariz E, Oyarbide A, Morales X, Ortiz‐espinosa S, Ruiz‐fernández de Córdoba B, Cochonneau D, Cornago I, Heymann D, Argemi J, D'avola D, Sangro B, Lecanda F, Pio R, Cortés‐domínguez I, Ortiz‐de‐solórzano C. Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10331] [Reference Citation Analysis]
7 Liu Y, Li R, Zhang L, Guo S. Nanomaterial-Based Immunocapture Platforms for the Recognition, Isolation, and Detection of Circulating Tumor Cells. Front Bioeng Biotechnol 2022;10:850241. [DOI: 10.3389/fbioe.2022.850241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Conde I, Ribeiro AS, Paredes J. Breast Cancer Stem Cell Membrane Biomarkers: Therapy Targeting and Clinical Implications. Cells 2022;11:934. [DOI: 10.3390/cells11060934] [Reference Citation Analysis]
9 Brown MS, Muller KE, Pattabiraman DR. Quantifying the Epithelial-to-Mesenchymal Transition (EMT) from Bench to Bedside. Cancers (Basel) 2022;14:1138. [PMID: 35267444 DOI: 10.3390/cancers14051138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Altei WF, Pachane BC, Souza C, Marques MMC, Selistre-de-Araújo H. New insights into the discovery of drugs for triple-negative breast cancer metastasis. Expert Opin Drug Discov 2022;:1-12. [PMID: 35179448 DOI: 10.1080/17460441.2022.2039619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhao M, Mi D, Ferdows BE, Li Y, Wang R, Li J, Patel D, Kong N, Shi S, Tao W. State-of-the-art nanotechnologies for the detection, recovery, analysis and elimination of liquid biopsy components in cancer. Nano Today 2022;42:101361. [DOI: 10.1016/j.nantod.2021.101361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Xia P, Liu D. Cancer stem cell markers for liver cancer and pancreatic cancer. Stem Cell Research 2022. [DOI: 10.1016/j.scr.2022.102701] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 He S, Yu S, Wei J, Ding L, Yang X, Wu Y. New horizons in the identification of circulating tumor cells (CTCs): An emerging paradigm shift in cytosensors. Biosens Bioelectron 2022;203:114043. [PMID: 35121449 DOI: 10.1016/j.bios.2022.114043] [Reference Citation Analysis]
14 Vegliante R, Pastushenko I, Blanpain C. Deciphering functional tumor states at single-cell resolution. EMBO J 2021;:e109221. [PMID: 34918370 DOI: 10.15252/embj.2021109221] [Reference Citation Analysis]
15 Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, Zhu F, Zhou D, Zheng S, Chen Y, Zhou J. Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther 2021;6:404. [PMID: 34803167 DOI: 10.1038/s41392-021-00817-8] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
16 Tieng FYF, Abu N, Nasir SN, Lee LH, Ab Mutalib NS. Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells. Diagnostics (Basel) 2021;11:2136. [PMID: 34829483 DOI: 10.3390/diagnostics11112136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 He S, Wei J, Ding L, Yang X, Wu Y. State-of-the-arts techniques and current evolving approaches in the separation and detection of circulating tumor cell. Talanta 2021;239:123024. [PMID: 34952370 DOI: 10.1016/j.talanta.2021.123024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Sanches SM, Braun AC, Calsavara VF, Barbosa PNVP, Chinen LTD. Comparison of hormonal receptor expression and HER2 status between circulating tumor cells and breast cancer metastases. Clinics (Sao Paulo) 2021;76:e2971. [PMID: 34644733 DOI: 10.6061/clinics/2021/e2971] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Kim MW, Park S, Lee H, Gwak H, Hyun KA, Kim JY, Jung HI, Il Kim S. Multi-miRNA panel of tumor-derived extracellular vesicles as promising diagnostic biomarkers of early-stage breast cancer. Cancer Sci 2021. [PMID: 34626053 DOI: 10.1111/cas.15155] [Reference Citation Analysis]
20 Cortés-Hernández LE, Eslami-S Z, Costa-Silva B, Alix-Panabières C. Current Applications and Discoveries Related to the Membrane Components of Circulating Tumor Cells and Extracellular Vesicles. Cells 2021;10:2221. [PMID: 34571870 DOI: 10.3390/cells10092221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Ladurner M, Wieser M, Eigentler A, Seewald M, Dobler G, Neuwirt H, Kafka M, Heidegger I, Horninger W, Bektic J, Klocker H, Obrist P, Eder IE. Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer. Biomedicines 2021;9:1004. [PMID: 34440208 DOI: 10.3390/biomedicines9081004] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 Sinoquet L, Jacot W, Gauthier L, Pouderoux S, Viala M, Cayrefourcq L, Quantin X, Alix-Panabières C. Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer. Clin Chem 2021:hvab131. [PMID: 34355741 DOI: 10.1093/clinchem/hvab131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Jiang H, Gu X, Zuo Z, Tian G, Liu J. Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis. PLoS One 2021;16:e0254433. [PMID: 34242363 DOI: 10.1371/journal.pone.0254433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Brown TC, Sankpal NV, Gillanders WE. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition. Biomolecules 2021;11:956. [PMID: 34209658 DOI: 10.3390/biom11070956] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
25 Alix-Panabières C, Pantel K. Liquid biopsy: from discovery to clinical implementation. Mol Oncol 2021;15:1617-21. [PMID: 34075709 DOI: 10.1002/1878-0261.12997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Li F, Zeng Z, Hamilton D, Zu Y, Li Z. EpCAM-Targeting Aptamer Radiotracer for Tumor-Specific PET Imaging. Bioconjug Chem 2021;32:1139-45. [PMID: 34014641 DOI: 10.1021/acs.bioconjchem.1c00188] [Reference Citation Analysis]
27 Chen QY, Chen YX, Han QY, Zhang JG, Zhou WJ, Zhang X, Ye YH, Yan WH, Lin A. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer. Front Immunol 2021;12:679090. [PMID: 34054869 DOI: 10.3389/fimmu.2021.679090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
28 Silva VSE, Abdallah EA, Brito ABC, Braun AC, Tariki MS, de Mello CAL, Calsavara VF, Riechelmann R, Chinen LTD. Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer. Diagnostics (Basel) 2021;11:502. [PMID: 33809053 DOI: 10.3390/diagnostics11030502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Singh B, Arora S, D'Souza A, Kale N, Aland G, Bharde A, Quadir M, Calderón M, Chaturvedi P, Khandare J. Chemo-specific designs for the enumeration of circulating tumor cells: advances in liquid biopsy. J Mater Chem B 2021;9:2946-78. [PMID: 33480960 DOI: 10.1039/d0tb02574g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]